IHS Chemical Week

Omnova beats estimates despite net income decline

11:24 AM MDT | June 27, 2013

Omnova’s fiscal second-quarter net income declined 58.6% year-on-year (YOY), to $2.9 million, on sales down 11.9%, to $270.8 million. Adjusted earnings from continuing operations, excluding restructuring and refinancing costs, totaled $7.1 million, or 16 cts/share, down 14.5% YOY but ahead of analysts’ consensus of 15 cts/share, as reported by Thomson Reuters. Omnova’s fiscal second-quarter ended on 31 May. "We have made a number of structural improvements that we expect will contribute to improved results during the remainder of the year, including new...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 


Forgot your user ID or password? Click here to have it sent to you.

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa